FDA Inspection 1202885 - Novartis Singapore Pharmaceutical Manufacturing Pte. - March 03, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Novartis Singapore Pharmaceutical Manufacturing Pte., with an inspection on March 3, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Novartis Singapore Pharmaceutical Manufacturing Pte.
Inspection Date: March 3, 2023
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · 867d6c5c-4948-4698-82d2-787effd04fbc